Correspondence 0001171843-24-002976 from Axe Compute Inc. (AGPU)
Axe Compute Inc.
Date: May 20, 2024 · CIK: 0001446159 · Accession: 0001171843-24-002976
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-279123
Letter
PREDICTIVE ONCOLOGY INC.
91 43rd Street, Suite 110
Pittsburgh, PA 15201
May 20, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Ms. Jane Park, Staff Attorney
Re: Predictive Oncology Inc.
Acceleration Request for Registration Statement on Form S-3, as amended
File No. 333-279123
Requested Date: May 21, 2024
Requested Time: 5:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Predictive Oncology Inc. (the “Registrant”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-279123) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or as soon as practicable thereafter, or at such later time as the Registrant or its counsel may orally request (the “Registration Statement Acceleration Request”) via telephone call to the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”). The Registrant hereby authorizes Alan Seem of DLA Piper LLP (US), counsel for the Registrant, to make such request on the Registrant’s behalf.
We request that we be notified of the effectiveness of the Registration Statement by telephone to Alan Seem of DLA Piper LLP (US) at 650-833-2050, or in his absence, Amanda Maki of DLA Piper LLP (US) at 713-425-8461. Thank you for your assistance.
Very truly yours,
/s/ Raymond Vennare
Show Raw Text
CORRESP 1 filename1.htm PREDICTIVE ONCOLOGY INC. 91 43rd Street, Suite 110 Pittsburgh, PA 15201 May 20, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Ms. Jane Park, Staff Attorney Re: Predictive Oncology Inc. Acceleration Request for Registration Statement on Form S-3, as amended File No. 333-279123 Requested Date: May 21, 2024 Requested Time: 5:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Predictive Oncology Inc. (the “Registrant”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-279123) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or as soon as practicable thereafter, or at such later time as the Registrant or its counsel may orally request (the “Registration Statement Acceleration Request”) via telephone call to the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”). The Registrant hereby authorizes Alan Seem of DLA Piper LLP (US), counsel for the Registrant, to make such request on the Registrant’s behalf. We request that we be notified of the effectiveness of the Registration Statement by telephone to Alan Seem of DLA Piper LLP (US) at 650-833-2050, or in his absence, Amanda Maki of DLA Piper LLP (US) at 713-425-8461. Thank you for your assistance. Very truly yours, /s/ Raymond Vennare Raymond Vennare Chief Executive Officer cc: Raymond Vennare (Chief Executive Officer, Predictive Oncology Inc.) Josh Blacher (Interim Chief Financial Officer, Predictive Oncology Inc.) Alan. Seem (DLA Piper LLP (US)) Amanda Maki (DLA Piper LLP (US))